Humana Inc. v. Bausch Health Companies Inc. et al
Humana Inc. |
Bausch Health Companies Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd., Salix Pharmaceuticals, Inc., Santarus, Inc. and Assertio Therapeutics, Inc. |
3:2020cv05251 |
July 30, 2020 |
US District Court for the Northern District of California |
William Alsup |
Donna M Ryu |
Anti-Trust |
15 U.S.C. ยง 1 |
Plaintiff |
Docket Report
This docket was last retrieved on August 10, 2020. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 11 CLERK'S NOTICE ON REASSIGNMENT RESETTING INITIAL CASE MANAGEMENT CONFERENCE. The Initial Case Management Conference set for 11/4/2020 is continued to 11/5/2020 11:00 AM before Judge William Alsup. Case Management Statement due by 10/29/2020. Standing orders can be downloaded from the Court's webpage at www.cand.uscourts.gov/whaorders. This proceeding will be held by AT&T Conference Line. The court circulates the following conference number to allow the equivalent of a public hearing by telephone.For conference line information, see: https://apps.cand.uscourts.gov/telhrg/ All counsel, members of the public and press please use the following dial-in information below to access the conference line: Dial In: (888) 684-8852Access Code: 3707514The Court may be in session with proceedings in progress when you connect to the conference line. Therefore, mute your phone if possible and wait for the Court to address you before speaking on the line. For call clarity, parties shall NOT use speaker phone or earpieces for these calls, and where at all possible, parties shall use landlines.PLEASE NOTE: Persons granted access to court proceedings held by telephone or videoconference are reminded that photographing, recording, and rebroadcasting of court proceedings, including screenshots or other visual copying of a hearing, is absolutely prohibited. See General Order 58 at Paragraph III. Case Management Statement due by 10/29/2020. Initial Case Management Conference set for 11/5/2020 11:00 AM in San Francisco, Chambers. (This is a text-only entry generated by the court. There is no document associated with this entry.)(amd2S, COURT STAFF) (Filed on 8/10/2020) |
Filing 10 Case Reassigned to Judge William Alsup. Magistrate Judge Donna M. Ryu no longer assigned to the case. Notice: The assigned judge participates in the Cameras in the Courtroom Pilot Project. See General Order No. 65 and http://cand.uscourts.gov/cameras. (mbcS, COURT STAFF) (Filed on 8/10/2020) |
Filing 9 ORDER RELATING CASE TO NO. C 19-05822 WHA. Signed by Judge Alsup on 8/7/2020. (whalc2, COURT STAFF) (Filed on 8/7/2020) |
Filing 8 Summons Issued as to Assertio Therapeutics, Inc., Bausch Health Companies Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd., Santarus, Inc.. (jmlS, COURT STAFF) (Filed on 8/5/2020) |
Filing 7 CLERK'S NOTICE: Plaintiff filed an administrative motion to consider whether this case is related to In Re Glumetza Antitrust Litigation, Case No. 19-cv-05822-WHA (N.D. Cal.). Pursuant to Civil Local Rule 3-12(b), motions to relate must be filed in the lowest-numbered case (here, the case before Judge Alsup). Accordingly, the administrative motion is terminated. (This is a text-only entry generated by the court. There is no document associated with this entry.) (dmrlc3, COURT STAFF) (Filed on 8/4/2020) |
Filing 6 MOTION to Relate Case Administrative Motion to Consider Whether Cases Should be Related filed by Humana Inc.. (Schneider, Todd) (Filed on 8/4/2020) |
Filing 5 Proposed Summons. (Attachments: #1 Addendum)(Schneider, Todd) (Filed on 8/4/2020) |
Filing 4 Initial Case Management Scheduling Order with ADR Deadlines: Case Management Statement due by 10/28/2020. Initial Case Management Conference set for 11/4/2020 01:30 PM in Oakland, Courtroom 4, 3rd Floor. (jmlS, COURT STAFF) (Filed on 7/31/2020) |
Filing 3 Case assigned to Magistrate Judge Donna M. Ryu. Counsel for plaintiff or the removing party is responsible for serving the Complaint or Notice of Removal, Summons and the assigned judge's standing orders and all other new case documents upon the opposing parties. For information, visit E-Filing A New Civil Case at http://cand.uscourts.gov/ecf/caseopening.Standing orders can be downloaded from the court's web page at www.cand.uscourts.gov/judges. Upon receipt, the summons will be issued and returned electronically. Counsel is required to send chambers a copy of the initiating documents pursuant to L.R. 5-1(e)(7). A scheduling order will be sent by Notice of Electronic Filing (NEF) within two business days. Consent/Declination due by 8/14/2020. (anjS, COURT STAFF) (Filed on 7/31/2020) |
#Electronic filing error. A maximum of THREE summons will be issued. Please list all defendants on ONE summons or multiple defendants on THREE summons and re-file in its entirety. Re: #2 Proposed Summons filed by Humana Inc. (jmlS, COURT STAFF) (Filed on 7/31/2020) |
Filing 2 Proposed Summons. (Schneider, Todd) (Filed on 7/30/2020) |
Filing 1 COMPLAINT with jury demand against Assertio Therapeutics, Inc., Bausch Health Companies Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc., Salix Pharmaceuticals, Ltd., Santarus, Inc. ( Filing fee $ 400, receipt number 0971-14755566.). Filed by Humana Inc.. (Attachments: #1 Civil Cover Sheet)(Schneider, Todd) (Filed on 7/30/2020) Modified on 7/31/2020 (jmlS, COURT STAFF). |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the California Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.